+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
AGARWALEYE

Dr. Agarwals Health Care Share Price

₹478.00 -4.2 (-0.87%)

31 Jul, 2026 3:59 PM (IST)

Dr. Agarwals Health Care live price: ₹478.00. It opened at ₹482 vs previous close ₹482; intraday high/low: ₹490/₹474. The 50 & 200 DMA stand at ₹473.60/₹459.00.

Dr. Agarwals Health Care Performance

  • Today's Low
  • ₹474
  • Today's High
  • ₹490
  • 52 Week Low
  • ₹401
  • 52 Week High
  • ₹568
  • Open Price₹482
  • Previous Close₹482
  • Volume45,256
  • 50 DMA₹473.60
  • 100 DMA₹467.30
  • 200 DMA₹459.00

Dr. Agarwals Health Care Chart

Investment Returns

  • Over 1 Month -0.2%
  • Over 3 Month + 7.39%
  • Over 6 Month + 10.46%
  • Over 1 Year + 4.63%

Smart Investing Starts Here Start SIP with Dr. Agarwals Health Care for Steady Growth!

Invest Now

Dr. Agarwals Health Care Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 113.8
  • PEG Ratio
  • 1.9
  • Market Cap Cr
  • 15,154
  • P/B Ratio
  • 7.5
  • Average True Range
  • 15.2
  • EPS
  • 4.2
  • Dividend Yield
  • 0
  • MACD Signal
  • 3
  • RSI
  • 48.77
  • MFI
  • 56.64

Latest Stock News Updates

Dr. Agarwals Health Care Ltd - 544350 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Analyst / Earnings Conference call to discuss the Unaudited Financial Results (Standalone & Consolidated) of the Company For The Quarter Ended June 30, 2026, is attached

Dr. Agarwals Health Care Ltd - 544350 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2026

Dr. Agarwals Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.

Dr. Agarwals Health Care Ltd - 544350 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Advertisement of Notice of Hearing of the Company''s Petition in relation to the Scheme of Amalgamation between Dr. Agarwal''s Eye Hospital Limited and Dr. Agarwal''s Health Care Limited, is enclosed.

Dr. Agarwals Health Care Financials

Dr. Agarwals Health Care Technicals

EMA & SMA

Current Price
₹478.00
-4.2 (-0.87%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹481.60
  • 50 Day
  • ₹473.60
  • 100 Day
  • ₹467.30
  • 200 Day
  • ₹459.00

Resistance and Support

480.67 Pivot Speed
  • R3 503.40
  • R2 496.70
  • R1 487.40
  • S1 471.30
  • S2 464.60
  • S3 455.20

Dr. Agarwals Health Care Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-04 Quarterly Results
2026-05-21 Audited Results
2026-02-03 Quarterly Results
2025-10-30 Quarterly Results
2025-08-12 Quarterly Results

Dr. Agarwals Health Care Shareholding Pattern

57.97%
32.34%
6.02%
1.97%
1.7%

About Dr. Agarwals Health Care

Dr Agarwal's Health Care is primarily engaged in running, owning and managing eye care hospitals, opticals, pharmacies, etc. and related services. View More
  • NSE Symbol
  • AGARWALEYE
  • BSE Symbol
  • 544350
  • ISIN
  • INE943P01029

Similar Stocks to Dr. Agarwals Health Care

Dr. Agarwals Health Care FAQs

Dr. Agarwals Health Care share price is ₹478 As on 01 August, 2026 | 18:54

The Market Cap of Dr. Agarwals Health Care is ₹15153.9 Cr As on 01 August, 2026 | 18:54

The P/E ratio of Dr. Agarwals Health Care is 113.8 As on 01 August, 2026 | 18:54

The PB ratio of Dr. Agarwals Health Care is 7.5 As on 01 August, 2026 | 18:54

The 52 week High & Low of Dr. Agarwals Health Care is ₹568/₹401 respectively As on 01 August, 2026 | 18:54

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23